Resolution Therapeutics’ founders present clinical proof-of-concept for macrophage cell therapy in end-stage liver disease at AASLD
Edinburgh and London, UK, 13 November 2023 - 1-year results of the MATCH Phase 2 trial of macrophage cell therapy in cirrhosis presented at AASLD
READ MORE +